• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Health Products Association - China Executive Director Reflects on Market Dynamics, Challenges

    Blood Sugar Management: Personalized Testing Drives Home The Need for Early Intervention

    New and Evolving Formulation Options Must Be Mindful of Blood Sugar Maintenance

    Tapping Functional Beverages to Meet Modern Wellness Needs

    Adaptogens: Where Ancient Remedies Meet Modern Wellness Products
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Pharmavite Expands in Ohio with $200 Million Investment

    Nestlé Health Science Expands in New Zealand with Deal to Buy The Better Health Company

    Younger Consumers Drive Growing Demand for Ingestible Beauty and Skin Care Products

    NOW Identifies Misleading Certificate of Analysis for Supplements Sold on Amazon

    Kensing Acquires Vitae Naturals
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Kensing Acquires Vitae Naturals

    Lynside® Forte B offers full range of B-vitamin benefits with nutritional yeast

    CoQ10 and Royal Jelly Supplementation May Improve High Intensity Exercise

    Shiitake Mushroom Extract Appears Helpful in HPV Infections

    United Plant Savers Launches First Film Festival
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Pharmavite Expands in Ohio with $200 Million Investment

    Nestlé Health Science Expands in New Zealand with Deal to Buy The Better Health Company

    Younger Consumers Drive Growing Demand for Ingestible Beauty and Skin Care Products

    NOW Identifies Misleading Certificate of Analysis for Supplements Sold on Amazon

    Kensing Acquires Vitae Naturals
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Younger Consumers Drive Growing Demand for Ingestible Beauty and Skin Care Products

    Lynside® Forte B offers full range of B-vitamin benefits with nutritional yeast

    CoQ10 and Royal Jelly Supplementation May Improve High Intensity Exercise

    Shiitake Mushroom Extract Appears Helpful in HPV Infections

    Upcycled Coffeeberry® Cascara Offers Versatility in Functional Beverage Development
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    JRS Pharma

    Botanic Healthcare LLC

    KLK OLEO

    Gencor

    Atlantia Clinical Trials
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    JRS Pharma

    Botanic Healthcare LLC

    KLK OLEO

    Gencor

    Atlantia Clinical Trials
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Health E-Insights

    An Interview with Manoj Dadlani, CEO, CosmosID

    Dadlani is CEO of the Maryland-based provider of industry-leading solutions for unlocking the microbiome.

    An Interview with Manoj Dadlani, CEO, CosmosID
    Related CONTENT
    • Baker Dillon Group LLC
    • CBD Talk Podcast Host Dawn Peacock: Slashing Stigmas & Countering Misinformation
    • An Interview with Ned Becker of Columbia Nutritional
    • Cannovia: Clearing Up CBD Market Confusion
    • Emerald Bioceuticals: Broad Support for the Endocannabinoid System
    By Sheldon Baker10.07.19
    Previously, Dadlani served as a partner at Applied Value Group, a management consulting and investment firm, and was co-founder and CEO at Rasa Industries, Ltd., a leading beverage manufacturing company. Dadlani has substantial experience in strategy, mergers and acquisitions, supply chain management, product development, marketing and business development. He received his bachelors and master’s degrees in biological engineering from Cornell University.

      
    Health E-Insights: CosmosID provides Next-Generation Sequencing (NGS) and Bioinformatics solutions. Please explain.
     
    Dadlani: CosmosID is a microbial genomics company at its core and we're the industry leaders in rapid, high resolution identification and characterization of microorganisms. We offer software as well as end-to-end sequencing and analysis services optimized for pharmaceutical, nutritional R&D, food safety, and molecular diagnostics. We leverage over 10 years of experience and expertise in the field of microbiome analysis and support industry and academia across the entire NGS workflow, from study design to sample collection, extraction, library preparation, sequencing, bioinformatics, publication and regulatory support. What ultimately differentiates CosmosID is its bioinformatics platform. We've been continuously curating the world's largest reference database of microbial genomes as well as antimicrobial resistance and virulence data and our algorithms have been independently validated to quantitatively identify bacteria, viruses, fungi, and protists down to strain-level, with industry-leading sensitivity and precision. While conventional data analysis methods can take many hours per sample our platform returns results within minutes and directly into a user-friendly cloud application with robust interactive visualization tools. You can test out our platform by creating a free account at app.cosmosid.com.
     
    Health E-Insights: Your company’s origin is an interesting one.
     
    Dadlani: It certainly is. The company was founded in 2008 by Professor Rita Colwell; a world-renowned microbiologist and one of the foremost experts in environmental metagenomics. Her resume includes being an author of over 800 publications, 19 books; and Rita has received 64 honorary degrees. Outside of the world of research, Rita is mostly known in the public eye for having been the first female head of the National Science Foundation from 1998 to 2004, under the Clinton and Bush administrations. During her time, she and a team of experts were tasked with tracking the source of the anthrax outbreak in 2001. Tracking such outbreaks at that time was exceedingly difficult, given the tools at one’s disposal. This inspired Rita to develop a bioinformatics platform that could identify organisms down to the strain-level within complex microbiota samples to not only address future bio-threats but impact clinical microbiology and health-relevant industries and do so in a rapid and accurate manner. This was all based on an emerging technology at the time, one which we use regularly today, Whole-Genome Sequencing. Ten years later, the platform Rita had envisioned is the core of the CosmosID technology. It's commercialized and currently being used by hundreds of scientists around the world.
     
    Health E-Insights: Do your services focus on supplements as well as pharmaceuticals?
     
    Dadlani: Absolutely. We see a lot of crossover between these two industries in the context of microbiome R&D. Both industries are interested in the same questions and sample types when it comes to understanding the impact of nutrition, supplements, or novel drugs on our health and the gut, skin, oral, or vaginal microbiome. We just see it as two sides of the same coin. The difference is ultimately how the research will be applied and in what regulatory environment. There have been tremendous strides in the world of microbial genomics in the last few years and given the decreasing cost in NGS, there's been an explosion of interest and research being done in R&D for supplements and nutraceuticals. The exact application of that research looks very different depending on which company you speak to, but an example would be to discover novel nutritional supplements that modulate the microbiome to achieve a desired effect on health and wellness. This can be in the form of a pre- or probiotic, which are popular and obvious choices, but also through other extracts and natural ingredients. Another interesting application is to go back and look on your shelf of already existing products and ingredients and run a retrospective study on how they may be impacting the microbiome of consumers. Some products may be impacting the microbiome positively and you don't even know it. Additionally, this same technology is used in quality control of the strains that go into a probiotic. Using NGS, we can validate and quantify whether the right strains are actually in the products that consumers are buying and ensure that the labeling claims are correct.
     
    Health E-Insights: What if any are the emerging trends in the microbiome category?
     
    Dadlani: There are quite a few increasingly popular and emerging research areas in the microbiome such as sports nutrition and infant health, but one that's arguably the most exciting is the gut-brain axis. There's a tremendous amount of research emerging to suggest that through interactions with the host immune system or via various neurotransmitter-like metabolites, the microbiome could be having a major impact on mental health which means, if harnessed correctly, we could see a new wave of probiotic products developed specifically for conditions like stress, mood, and sleep disorders. We still have a way to go in terms of understanding which bugs impact our mood, for example, and how, but it's exciting to think that consumers may soon have more options when it comes to improving their mental health and well-being before having to take prescription medication.
     
    Health E-Insights: Will advances in technology enhance what your company does?
     
    Dadlani: Without a doubt. Our company leverages technologies developed NGS instrument providers such as Illumina and ThermoFisher and so as we start to see improvements and efficiencies introduced to the NGS workflow by emerging kits and products, we plan to continue improving the quality of data we provide to our customers, but do so in a more efficient and cost-effective manner. Currently, over 90% of the microbiome space relies on short-reading sequencing by instrument providers. But there are many in the industry that believe that long-read sequencing is the future, and for good reasons. Our bioinformatics platform is already compatible with this new data type and we're keeping a close eye on long-read sequencing as costs decrease so that we can leverage the CosmosID platform in other innovative ways.
     
    Health E-Insights: What new competition do you envision within the next 3-5 years?
     
    Dadlani: I’m incredibly excited about the nutraceutical space over the next five years. I feel that consumers are taking a much closer look at their how supplements can improve their well-being and are spending serious dollars on products that they feel are beneficial. My prediction in the space is that as consumers become more educated the supplement companies that will win are those who have invested in studies to show stronger scientific data to back their claims. Additionally, lifestyle diagnostic tests, will also guide consumers in personalization of their nutraceutical choices. From a competitive landscape, I think we’ll see companies that embrace transparency in their trials, as well as embrace personalization to lead the pack.
     
    Health E-Insights: What excites you most about what you do?
     
    Dadlani: We’re fortunate to be part of a game-changing technological revolution in microbiology. Today, using DNA sequencing, we’re able to view microorganisms that previously could not be cultured or studied and understand their effects on improving human health. As a biological engineer, being able to translate this new knowledge into businesses and products that can aid in improving general health and possibly curing diseases is what keeps me excited every day.
     
    Health E-Insights: Can you name a person who has had a tremendous impact on you as a leader?
     
    Dadlani: It would be hard for me to just name one person here, so I’ll take the liberty to name two. The first one is Dr. Dan Luo, my research advisor at Cornell University in the department of Biological and Environmental Engineering. He taught me that you can apply biology to solve engineering problems in ways that do not apply to traditional biology paradigms. An example of his work is using DNA as a synthetic material to deliver a drug and evade traditional human immune responses, rather than as a traditional vector of genetic code. Overall, he has taught me to push the boundaries in problem solving and think out of the box to find solutions. The other person that has impacted me significantly as a leader is Bruce Grant, the founder and chairman of the Applied Value Group, the organization I joined after graduating from Cornell. The two fundamental principles that Bruce always taught are to make data driven decisions that allow us to always be fact-based and how to efficiently grow an organization through the key principles of lean growth: focus, simplicity, and speed.

      
    Sheldon Baker is CEO of the Baker Dillon Group LLC and has created numerous nutraceutical brand marketing communications and public relations campaigns for many well-known supplement and food industry companies. For Health E-Insights interview consideration or brand marketing consulting, contact him at SBaker@BakerDillon.com.
     
    Related Searches
    • Sports Nutrition
    • Nutraceutical
    • microbiome
    • sleep
    Related Knowledge Center
    • Probiotics & Prebiotics
    • Digestive Health
    • Healthcare Trends
    Suggested For You
    Baker Dillon Group LLC Baker Dillon Group LLC
    CBD Talk Podcast Host Dawn Peacock: Slashing Stigmas & Countering Misinformation CBD Talk Podcast Host Dawn Peacock: Slashing Stigmas & Countering Misinformation
    An Interview with Ned Becker of Columbia Nutritional An Interview with Ned Becker of Columbia Nutritional
    Cannovia: Clearing Up CBD Market Confusion Cannovia: Clearing Up CBD Market Confusion
    Emerald Bioceuticals: Broad Support for the Endocannabinoid System Emerald Bioceuticals: Broad Support for the Endocannabinoid System
    Balanced Health Botanicals: Fueling The CBD Movement Balanced Health Botanicals: Fueling The CBD Movement
    Mile High Labs: Stephen Mueller & The Mile High Monster Mile High Labs: Stephen Mueller & The Mile High Monster
    An Interview with Tracey Seipel, ND, of the Seipel Group An Interview with Tracey Seipel, ND, of the Seipel Group
    Area Code 420 Has Arrived Area Code 420 Has Arrived
    An Interview with Christopher Detzel of Entera Health An Interview with Christopher Detzel of Entera Health
    An Interview with Ohad Cohen of Gadot Biochemical Industries An Interview with Ohad Cohen of Gadot Biochemical Industries

    Related Buyers Guide Companies

    • Baker Dillon Group LLC

      ...
      Sheldon Baker, Chief Executive Officer 11.05.21

    • Consumer Trends | Dietary Supplements | Healthcare Trends | Herbs & Botanicals
      CBD Talk Podcast Host Dawn Peacock: Slashing Stigmas & Countering Misinformation

      CBD Talk Podcast Host Dawn Peacock: Slashing Stigmas & Countering Misinformation

      Podcast focused on relaying science to the public in a way that’s easy to understand.
      By Sheldon Baker 10.08.19

    • Contract Manufacturing | Dietary Supplements
      An Interview with Ned Becker of Columbia Nutritional

      An Interview with Ned Becker of Columbia Nutritional

      Over the course of his career, Becker has worked with hundreds of different brands.
      By Sheldon Baker 09.09.19


    • Herbs & Botanicals | Quality & Safety
      Cannovia: Clearing Up CBD Market Confusion

      Cannovia: Clearing Up CBD Market Confusion

      CEO Brian Baum discusses the future of CBD innovation and product development.
      By Sheldon Baker 08.30.19

    • Consumer Trends | Dietary Supplements | Healthcare Trends | Herbs & Botanicals | Quality & Safety
      Emerald Bioceuticals: Broad Support for the Endocannabinoid System

      Emerald Bioceuticals: Broad Support for the Endocannabinoid System

      With a 25-year history of leading innovative and cutting-edge companies, Jade Beutler is an accomplished natural products industry executive.
      By Sheldon Baker 08.12.19

    Loading, Please Wait..
    Trending
    • Three Grams Of Omega-3s May Be Optimal Dose For Reducing Blood Pressure
    • 3 grams of Omega-3s May be Optimal Dose for Reducing Blood Pressu
    • High Blood DHA Levels Linked To 49% Reduced Risk Of Alzheimer’s
    • CoQ10 And Royal Jelly Supplementation May Improve High Intensity Exercise
    Breaking News
    • Pharmavite Expands in Ohio with $200 Million Investment
    • Nestlé Health Science Expands in New Zealand with Deal to Buy The Better Health Company
    • Younger Consumers Drive Growing Demand for Ingestible Beauty and Skin Care Products
    • NOW Identifies Misleading Certificate of Analysis for Supplements Sold on Amazon
    • Kensing Acquires Vitae Naturals
    View Breaking News >
    CURRENT ISSUE

    June 2022

    • Tapping Functional Beverages to Meet Modern Wellness Needs
    • Adaptogens: Where Ancient Remedies Meet Modern Wellness Products
    • New and Evolving Formulation Options Must Be Mindful of Blood Sugar Maintenance
    • Health Products Association - China Executive Director Reflects on Market Dynamics, Challenges
    • Blood Sugar Management: Personalized Testing Drives Home The Need for Early Intervention
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Pharmavite Expands in Ohio with $200 Million Investment
    Nestlé Health Science Expands in New Zealand with Deal to Buy The Better Health Company
    Younger Consumers Drive Growing Demand for Ingestible Beauty and Skin Care Products
    Coatings World

    Latest Breaking News From Coatings World

    Clariant’s Launches Dispersogen Flex 100
    Lincoln Tech Enters Partnership with AkzoNobel
    AkzoNobel Launches International Interzone 945GF
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    ENDRA Life Sciences Issued 27th Patent
    AI-Enabled SKOUT Device Improves Colorectal Cancer Screening
    Simon Johnson Appointed as Senior Business Development VP at MedAcuity
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Takeda to Expand U.S. Footprint
    Croda Pharma's Lipid Systems Capability to Support mRNA Vaccines
    WuXi STA Opens High-Potency API Plant
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Latest Updates About Cosmoprof North America
    Meet the Clean Beauty Brand for Dogs
    Paco Rabanne Introduces Elle Fanning as Ambassador for New ‘Fame’ Fragrance
    Happi

    Latest Breaking News From Happi

    Two-Part Skincare Product Patented by Estée Lauder Companies
    American Cleaning Institute Pens Letter to Congress Encouraging Examination of Recyclability Improvements
    The Expert Panel for Fragrance Safety Celebrates 55 Years
    Ink World

    Latest Breaking News From Ink World

    INX Launches INXFlex Contour for Shrink Sleeve Market
    Xerox Announces Unexpected Passing of Vice Chairman and CEO John Visentin
    MNYPIA Golf Outing Set to Tee Off on Aug. 17
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Meyers purchased by third generation of Dillon family
    Epson now shipping ColorWorks C4000 inkjet label printer
    Nobelus launches new films for prime labels
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    What You’re Reading on Nonwovens-Industry.com
    Daio, Livedo Partner to Recycle Diapers
    Suominen Launches Hydraspun Reserve
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    3D Systems and EMS-GRILTECH Enter Strategic Partnership
    AIP Researchers Develop Microfluidic-Based Soft Robotic Prosthetic
    David Sharp Named Global Marketing VP at Catalyst OrthoScience
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Impinj Launches E910 RFID Reader Chip for Next Generation Enterprise IoT
    onsemi Receives Recognition for Sustainability for Third Straight Year
    Xerox Announces the Unexpected Passing of Vice Chairman and CEO John Visentin

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login